Call for a Special Issue on “Uruguayan Society of Phytopathology (SUFIT): Plant protection for a sustainable agriculture” in the journal ⋘International Journal of Pest Management⋙ by 30th April 2022.
This special issue focuses on the management of plant diseases, weeds, and pests in Uruguay and the surrounding countries for facilitating agroecological transitions in crops with international or national importance.
Link: 🔗https://think.taylorandfrancis.com/special_issues/uruguayan-society-phytopathology-sustainable-agriculture/?_gl=1*19wghqn*_ga*MTY3MTA2MzcxMi4xNjUwNTUxMTU0*_ga_0HYE8YG0M6*MTY1MDU1MTE1NC4xLjEuMTY1MDU1MTg0Ny4w🔗
As the previous comment states, ⋘Nature Biotechnology⋙ is one of the best biotechnology journals regarding indexes and scores, but among biotechnology journals, it has a lower than average number of annual articles and perhaps the slowest publishing speed.
For example, ⋘Applied Microbiology and Biotechnology⋙ journal has 5 times greater annual article volume, and the median days until acceptance and publication are 61 and 21, respectively; while the median days until acceptance and publication in ⋘Nature Biotechnology⋙ are 139 and 38, respectively.
An interesting study in this journal: 🔗https://doi.org/10.1038/s41587-021-01058-4🔗
I think this funding has expired and I could not find any information about it online.
This text seems like it is from this advertisement from before 2008/09:
🔗http://rosmu.ru/activity/attach/announces/110/flyer_robert_bosch_junior_professorship.pdf🔗
On this link you can find all the necessary information:
🔗https://www.instantmarkets.com/view/ID166664373640858069231855523790534109273/Wideband_Communication_Links_in_Contested_Environments🔗
White papers will be considered if received by 30 September 2022, but to best align with projected funding the following submission dates are suggested:
FY18 by 6 April 2018
FY19 by 6 August 2018
FY20 by 5 August 2019
FY21 by 3 August 2020
FY22 by 2 August 2021
The deadline for this funding is not 30th April 2022 but 25 April 2022 (by noon).
Pilot and Project Grants cannot be given to research applications focusing on mesothelioma or therapies.
10 days left to apply for this funding!
However, I could not find additional information about this funding.
I have found a few external links with more information available only to subscribers (e.g. two links below), so I guess the best way to acquire details is to contact the above-mentioned email.
🔗https://govtribe.com/opportunity/federal-grant-opportunity/basic-education-quality-advancement-addendum-72051921r00002🔗
🔗https://www.developmentaid.org/grants/view/662687/basic-education-quality-advancement-addendum-to-higher-education-for-leadership-innovation-and-excha🔗
Like the previous comment, I also think that ⋘Aquaculture⋙ is a journal that is not quite efficient regarding time.
We submitted to this journal around two months ago, and we have not yet received any response from them.
This is quite a problem because if they reject our paper due to being out of their scope, we will spend quite some time tailoring it for another journal.
However, this is one of the best journals in the emerging field of aquaculture with quite interesting research articles and reviews, for example: 🔗https://doi.org/10.1016/j.aquaculture.2020.736286🔗
I have tried to find more information about this funding, but the link above does not work.
Here is the working link: 🔗https://www.governmentbids.com/government-bid-opportunity-public-12966076-en.jsa🔗
However, the due date for this funding is not 30th September 2022 but 21st June 2019.
The best way of learning is trying to understand it enough to be able to teach it to others.
Coming from the country with perhaps the best educational system in the world, Finland, this paper demonstrates that multimodal video project in a higher-education setting improves learning through positive emotions and increased motivation.
Instructional videos generated by university biology students provided the opportunity for students to learn in an unconventional manner and to be a valuable teaching resource for teachers.
The students were motivated to master the subject matter through reviewing and writing literature reviews before being able to generate instructional videos as they were motivated to form videos that they knew would be useful for others.
Positive emotions are the greatest driver behind improving learning and understanding.
As the previous comment states, ⋘Bioresource Technology⋙ (BITE) is one of the most time-efficient journals as the median days until acceptance and publication are 54 and 8, respectively.
This is perhaps my favorite journal due to its novel research topics, quality, and efficiency.
When I tried to publish a paper in this journal, they responded in a couple of days telling me that my paper is out of their scope, which is extremely appreciable as time is the most precious thing in publishing.
However, this journal has quite strict rules regarding the quantity (e.g. maximum 100 words in the conclusion, maximum 50 references in original research papers), even in the supplementary materials.
An interesting paper from this journal: 🔗https://doi.org/10.1016/j.biortech.2021.126265🔗
For the ⋘Small Business Innovation Research⋙ (SBIR), a **Small Business Concern** (i.e. a for-profit entity that maintains a place of business and operates primarily within the United States and is an individual partnership, corporation, limited liability company, joint venture, association, or trust that meets the size eligibility requirements) may apply as a **Standalone Applicant** (i.e. applying for funding on its own) or as the lead organization for a **Project Team** (i.e. entity with multiple players working collaboratively).
For the ⋘Small Business Technology Transfer⋙ (STTR), a **Small Business Concern** may apply only as the lead organization for a **Project Team** if it performs at least 40% of the work in Phase I, Phase II, and/or Phase IIS, as measured by the **Total Project Cost** (i.e. the sum of the Federal Government share and Prime Recipient share of total allowable costs).
🔗https://www.grants.gov/web/grants/view-opportunity.html?oppId=311429🔗
⋘Estuarine, Coastal and Shelf Science⋙ is an interdisciplinary journal focusing on the analysis of marine ecosystems between the upper tidal zone and the continental shelf from the aspects of botany, zoology, physical oceanography, geology, and sedimentology.
Unlike the previous comment here, I waited a year from the submission to online publication in this journal, but I submitted it in a special issue that might require more time than usual.
Together with the journal ⋘Ocean & Coastal Management⋙, this journal supports the annual conference ⋘ECSA⋙, which focuses on finding and using the best scientific knowledge for the sustainable management of coastal seas and estuaries (you can apply for ECSA 59 scheduled for September 2022 by 29 April).
An interesting paper from this journal: 🔗https://doi.org/10.1016/j.ecss.2020.106896🔗
Is there a cure for the deadliest disease known to man, malaria?
This study reported the findings of a three-day course of Artemisinin-Combination Therapy (ACT) pills in 228 children aged 6–59 months with malaria in 2018 in three Rwandan sites.
The authors confirmed the evidence of emerging artemisinin partial resistance - some of the children still had parasites after completing the treatment and more than 10% of the parasites had one of two mutations indicating resistance.
In science, one-time replication efforts do not tell the complete story, and this is especially troublesome in cancer investigation.
Two studies done by Errington et al. (2021) for 8-years attempted to replicate influential preclinical cancer research papers and they discovered that more than half of top cancer studies fail high-profile reproducibility attempts.
This project, called "Reproducibility Project: Cancer Biology" (RPCB), is one of the most vigorous reproducibility studies as it attempted to perform 50 experiments from 23 high-impact papers published during 2010–12 in journals including Science, Nature, and Cell.
In this (second) study, the authors presented their overall results where they were able to confirm the original results only in 46% of the attempted replications. Moreover, effect sizes were 85% smaller than originally stated mostly because animal (in vivo) experiments tend to generate smaller effect sizes than in vitro experiments.
As a solution, Errington et al. propose studies with bigger sample sizes, blinding, pre-registration of study plans, and larger statistical rigor.
In science, one-time replication efforts do not tell the complete story, and this is especially troublesome in cancer investigation.
Two studies done by Errington et al. (2021) for 8-years attempted to replicate influential preclinical cancer research papers and they discovered that more than half of top cancer studies fail high-profile reproducibility attempts.
This project, called "Reproducibility Project: Cancer Biology" (RPCB), is one of the most vigorous reproducibility studies as it attempted to perform 50 experiments from 23 high-impact papers published during 2010–12 in journals including Science, Nature, and Cell.
In this (first) study, authors cataloged the obstacles they encountered, such as unhelpful communication with original authors (32% of authors) as opposed to helpful author communication (26% of authors). Researchers needed more than 3.5 years to replicate some studies and spent up to $53,000 per experiment due to poor cooperation with original authors and the necessity to modify or overhaul experimental protocols.
As a solution, Errington et al. propose studies with bigger sample sizes, blinding, pre-registration of study plans, and larger statistical rigor.
Journal